Conservative groups have filed a federal suit against the Food and Drug Administration (FDA) in an attempt to overturn approval of Plan B, the "morning-after pill," for non-prescription sale to women 18 and older. The plaintiffs, who include Concerned Women for America and the Family Research Council, say that the FDA approved non-prescription Plan B under "unlawful political pressure" from Senators Hillary Clinton (D-NY) and Patty Murray (D-WA). funny picturesfunny imagesfunny photosfunny animal picturesfunny dog picturesfunny cat picturesfunny gifs
Plan B, a brand of emergency contraception that prevents pregnancy when taken within 120 hours of unprotected sex, was approved for non-prescription sale after Clinton and Murray in August 2006 placed a hold on the nomination of a new FDA head pending a Plan B decision. The senators did not specify a particular outcome, only urging that the FDA issue a decision on the drug. They acted after the FDA had postponed making a decision on non-prescription Plan B for over three years (such decisions usually take less than a year) despite the fact that two FDA expert advisory panels early on voted 27-1 that Plan B was safe for all ages and 23-4 in favor of non-prescription use, and despite the drug's overwhelming endorsement from national medical groups.
Many have blamed the FDA's years of delay on the Bush administration�s political interference. Dr. Susan Wood, who resigned from her post as director of the FDA's Office of Women's Health over the Plan B delay, said in a 2005 interview, "The agency was not acting independently. The leadership of the FDA overruled every level of staff review in the agency." The agency's head is appointed by the president.
The suit additionally charges that the FDA did not have the authority to create a new class of drug that does not require a prescription for women over 18, must be dispensed by a pharmacist, and requires a dual label for the over- and under-18 markets. These age and label restrictions were imposed by Bush-appointed FDA acting commissioner Andrew C. von Eschenbach and were met with frustration by reproductive-rights groups.
The lawsuit also erroneously claims that over-the-counter Plan B "causes an increase in the incidence of sexually transmitted diseases" and calls it "a dangerous drug."
"It's ridiculous to label as a 'dangerous drug' something that has been proven safer than aspirin, and it's ridiculous to withhold this medical breakthrough from women," says Eleanor Smeal, president of the Feminist Majority Foundation. "The irony is that some of the very people now claiming political interference are those who -- for more than three years -- used politics to trump good medical science."
Media Resources: Civil Action Lawsuit No. 07: 0668-RCL 4/12/07; Family Research Council 4/13/07; NPR.org 8/28/06; NYT 8/24/06; Nerve.com 10/16/05; FMF; Guttmacher Institute; Washington Times 4/13/07
10/12/2015 Report Finds Texas' HB2 Increases Abortion Wait Times - A new report released by the University of Texas at Austin, Texas Policy Evaluation Project found patients seeking abortions in Texas have experienced an increase in wait times since the passage of HB2, the 2013 Texas omnibus anti-abortion bill that attempts to cut off abortion access by requiring abortion providers in the state to fulfill medically unnecessary ambulatory surgical center requirements and secure hospital admitting privileges.
More than half of 42 clinics providing abortion in Texas have been forced to shut their doors since HB2 passed two years ago, leading Texas women to wait up to 20 days for a first consult at one of the surviving 18 reproductive health clinics operating in the state, the second most populous in the nation. . . .
10/9/2015 Federal Judge Orders Anti-Abortion Group to Cede Footage to NAF - On Tuesday, a federal judge ruled that anti-abortion group Center for Medical Progress (CMP) and its leader David Daleidan must turn over all previously unreleased "sting" videos and outtakes of National Abortion Federation (NAF) meetings the group obtained surreptitiously as part of a smear campaign against the abortion provider.
U.S. . . .
10/9/2015 Women Scientists Receive Less Funding Than Their Male Peers, Study Finds - According to a new study published by the Journal of the American Medical Association, male scientists receive twice as much financial support to kickstart their careers in science and medicine as their female counterparts, an early career inequity that could limit professional opportunities for women scientists throughout their working lives.
Conducted by Health Resources in Action (HRiA), analysts studied 219 biomedical researchers who had applied for early-career grant funding at 55 New England hospitals, universities and research facilities between 2012 and 2014. . . .